Latest news | MDR

Encouraging news for the MedTech field!

Encouraging news for the MedTech field!
October 2, 2023

Regulation (EU) 2017/745 on medical devices (MDR) has been fully applicable since May 26, 2021, even encompassing products without an intended medical purpose as listed in its Annex XVI. Considering that transitional provisions set out in the MDR have been extended by Regulation (EU) 2023/607, the European Commission has recently released a Q&A document that provides clarity on transitional provisions for compliance with common specifications (CS) for Annex XVI products, as outlined in Commission Implementing Regulation (EU) 2022/2346 (CS), as amended by Commission Implementing Regulation (EU) 2023/1194.

Manufacturers of Annex XVI products are required to have implemented CS by June 22, 2023. However, specific transitional provisions have been defined to address particular situations, such as when a notified body needs to be involved in the conformity assessment procedure, when the manufacturer is considering conducting a clinical investigation followed by a conformity assessment procedure that involves a notified body, and when the Annex XVI product is covered by an MDD certificate that is no longer valid.

Have a look at the infographic our experts have prepared for you to have always at hand: MDR Annex XVI transition period

At Asphalion we are experts in MedTech.

Contact us for all your MedTech needs:

You can also schedule a free 30-minutes meeting:

Search News & Events

  • Filter by category


Related news and events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting